Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: J Mol Cell Cardiol. 2021 Mar 3;155:66–77. doi: 10.1016/j.yjmcc.2021.02.014

Fig. 5. Comparison of model predictions and RNA sequencing data from Wang et al. (35) for sorafenib treatment.

Fig. 5.

Both model predictions and experimental results show an increase in Noxa, PUMA, and p53 activity in response to sorafenib.